Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association

Genomics

Volumn 89, Issue 6, 2007, Pages 655-665

  Yu, Chang En ^a,b   Seltman, Howard ^c   Peskind, Elaine R ^b,d   Galloway, Nichole ^a   Zhou, Peter X ^a   Rosenthal, Elisabeth ^e   Wijsman, Ellen M ^e   Tsuang, Debby W ^b,d   Devlin, Bernie ^f   Schellenberg, Gerard D ^a,b,g  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d Education   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g Division of Neurogenetics   (United States)

Author keywords

Alzheimer disease; Apolipoprotein E; Genetic association; Linkage disequilibrium; Molecular haplotyping; Selection

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MARKER; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34248142174     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2007.02.002     Document Type: Article

References (50)

1. Song Y., Stampfer M.J., and Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 141 (2004) 137-147
2. Schellenberg G.D., D'Souza I., and Poorkaj P. The genetics of Alzheimer's disease. Curr. Psychiatry Rep. 2 (2000) 158-164
3. Frikke-Schmidt R., Sing C.F., Nordestgaard B.G., and Tybjaerg-Hansen A. Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism. Hum. Genet. 115 (2004) 331-345
4. Farrer L.A., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356
5. Pedersen N.L., Posner S.F., and Gatz M. Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am. J. Med. Genet. 105 (2001) 724-728
6. Raber J., Huang Y., and Ashford J.W. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 25 (2004) 641-650
7. Artiga M.J., et al. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421 (1998) 105-108
8. Ramos M.C., et al. Neuronal specific regulatory elements in apolipoprotein E gene proximal promoter. NeuroReport 16 (2005) 1027-1030
9. Laws S.M., Hone E., Gandy S., and Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 84 (2003) 1215-1236
10. Stengard J.H., et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am. J. Hum. Genet. 71 (2002) 501-517
11. Nicodemus K.K., et al. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease. Neurogenetics 5 (2004) 201-208
12. Grehan S., Tse E., and Taylor J.M. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J. Neurosci. 21 (2001) 812-822
13. Shih S.J., et al. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem. 275 (2000) 31567-31572
14. Simonet W.S., Bucay N., Lauer S.J., and Taylor J.M. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268 (1993) 8221-8229
15. Shachter N.S., Zhu Y., Walsh A., Breslow J.L., and Smith J.D. Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus. J. Lipid Res. 34 (1993) 1699-1707
16. Zheng P., Pennacchio L.A., Le Goff W., Rubin E.M., and Smith J.D. Identification of a novel enhancer of brain expression near the apoE gene cluster by comparative genomics. Biochim. Biophys. Acta 1676 (2004) 41-50
17. Templeton A.R. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. Genetics 140 (1995) 403-409
18. Yu C.E., Devlin B., Galloway N., Loomis E., and Schellenberg G.D. ADLAPH: a molecular haplotyping method based on allele-discriminating long-range PCR. Genomics 84 (2004) 600-612
19. Fullerton S.M., et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67 (2000) 881-900
20. Rinaldo A., et al. Characterization of multilocus linkage disequilibrium. Genet. Epidemiol. 28 (2005) 193-206
21. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
22. Templeton A.R., et al. Tree scanning: a method for using haplotype trees in phenotype/genotype association studies. Genetics 169 (2005) 441-453
23. Crandall K.A., and Templeton A.R. Empirical tests of some predictions from coalescent theory with applications to intraspecific phylogeny reconstruction. Genetics 134 (1993) 959-969
24. Templeton A.R., Boerwinkle E., and Sing C.F. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping: I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 117 (1987) 343-351
25. Bullido M.J., et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18 (1998) 69-71
26. Lambert J.C., et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7 (1998) 1511-1516
27. Town T., et al. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252 (1998) 95-98
28. Wang J.C., Kwon J.M., Shah P., Morris J.C., and Goate A. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology 55 (2000) 1644-1649
29. Beyer K., et al. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very late onset. Neurosci. Lett. 326 (2002) 187-190
30. Lambert J.C., et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 59 (2002) 59-66
31. North B.V., et al. Further investigation of linkage disequilibrium SNPs and their ability to identify associated susceptibility loci. Ann. Hum. Genet. 68 (2004) 240-248
32. Carlson C.S., et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74 (2004) 106-120
33. Hanlon C.S., and Rubinsztein D.C. Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112 (1995) 85-90
34. Devlin B., Risch N., and Roeder K. Disequilibrium mapping: composite likelihood for pairwise disequilibrium. Genomics 36 (1996) 1-16
35. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22 (1999) 139-144
36. Humphries A.D., et al. Dissection of the mitochondrial import and assembly pathway for human Tom40. J. Biol. Chem. 280 (2005) 11535-11543
37. Gabriel K., Egan B., and Lithgow T. Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins. EMBO J. 22 (2003) 2380-2386
38. Blass J.P., Baker A.C., Ko L., Sheu R.K., and Black R.S. Expression of 'Alzheimer antigens' in cultured skin fibroblasts. Arch. Neurol. 48 (1991) 709-717
39. Blass J.P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. J. Neurosci. Res. 66 (2001) 851-856
40. Manczak M., Park B.S., Jung Y., and Reddy P.H. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromol. Med. 5 (2004) 147-162
41. Marques C.A., et al. Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J. Biol. Chem. 278 (2003) 28294-28302
42. Sieh W., Yu C.E., Bird T.D., Schellenberg G.D., and Wijsman E.M. Accounting for linkage disequilibrium among markers in linkage analysis: impact of haplotype frequency estimation and molecular haplotypes for a gene in a candidate region for Alzheimer's disease. Hum. Hered. 63 (2007) 26-34
43. Seltman H., Roeder K., and Devlin B. Evolutionary-based association analysis using haplotype data. Genet. Epidemiol. 25 (2003) 48-58
44. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
45. Li N., and Stephens M. Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics 165 (2003) 2213-2233
46. Crawford D.C., et al. Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat. Genet. 36 (2004) 700-706
47. Haviland M.B., Ferrell R.E., and Sing C.F. Association between common alleles of the low-density lipoprotein receptor gene region and interindividual variation in plasma lipid and apolipoprotein levels in a population-based sample from Rochester, Minnesota. Hum. Genet. 99 (1997) 108-114
48. Keavney B., et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum. Mol. Genet. 7 (1998) 1745-1751
49. Soubrier F., et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur. J. Hum. Genet. 10 (2002) 553-561
50. Sweet R.A., et al. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol. Psychiatry 10 (2005) 1026-1036